TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for CXCL17
check button Gene summary
Basic gene informationGene symbolCXCL17
Gene namechemokine (C-X-C motif) ligand 17
SynonymsDMC|Dcip1|UNQ473|VCC-1|VCC1
CytomapUCSC genome browser: 19q13.2
Type of geneprotein-coding
RefGenesNM_198477.1,
DescriptionC-X-C motif chemokine 17VEGF co-regulated chemokine 1VEGF coregulated chemokine 1dendritic cell and monocyte chemokine-like protein
Modification date20141207
dbXrefs MIM : 611387
HGNC : HGNC
HPRD : 18264
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_CXCL17
BioGPS: 284340
PathwayNCI Pathway Interaction Database: CXCL17
KEGG: CXCL17
REACTOME: CXCL17
Pathway Commons: CXCL17
ContextiHOP: CXCL17
ligand binding site mutation search in PubMed: CXCL17
UCL Cancer Institute: CXCL17
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Stomach
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)STAD
Reference showing the relevant tissue of CXCL17
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for CXCL17

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
THCA1.776094632-1.4306189273.2067135597.29E-125.68E-11
HNSC2.6114025945.830865385-3.2194627913.64E-095.02E-08
LUSC3.9566136757.118094067-3.1614803926.04E-143.21E-13
STAD2.8693201095.330423234-2.4611031250.01440.046133333
COAD-3.092820036-4.3393623431.2465423080.004730.011388385
PRAD0.7868722722.206756887-1.4198846150.003560.009693755
LUAD6.2372572857.305271078-1.0680137930.0009240.002033888


Top
TissGene-miRNA for CXCL17

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for CXCL17
TissGeneSNV for CXCL17

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.M1IBRCA1
p.E51GLIHC1
p.L8RCOAD1
p.H93NSTAD1
p.F80LBLCA1


Top
TissGeneCNV for CXCL17

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for CXCL17

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
TCGAfusionPortalPRADAGBMTCGA-32-1970-01AAC003682.1-CXCL17In-frameChr19:58063995Chr19:42938008


Top
TissGeneNet for CXCL17

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)


Top
TissGeneProg for CXCL17

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for CXCL17
TissGeneDrug for CXCL17

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for CXCL17

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C2239176Liver carcinoma3BeFree
umls:C0596263Carcinogenesis2BeFree
umls:C0007847Malignant tumor of cervix1BeFree
umls:C0009402Colorectal Carcinoma1BeFree
umls:C0027627Neoplasm Metastasis1BeFree
umls:C0085110Severe Combined Immunodeficiency1BeFree
umls:C0178874Tumor Progression1BeFree
umls:C0242379Malignant neoplasm of lung1BeFree
umls:C0265286Dyggve-Melchior-Clausen syndrome1BeFree
umls:C0278484Malignant neoplasm of colon stage IV1BeFree
umls:C0302592Cervix carcinoma1BeFree
umls:C0684249Carcinoma of lung1BeFree
umls:C1519670Tumor Angiogenesis1BeFree